{"id":44318,"date":"2022-05-25T11:03:10","date_gmt":"2022-05-25T09:03:10","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-blood-plasma-derivatives-market-report-2022-a-40-5-billion-market-in-2021-industry-trends-share-size-growth-opportunity-and-forecasts-to-2027-researchandmarkets-com\/"},"modified":"2022-05-25T11:03:10","modified_gmt":"2022-05-25T09:03:10","slug":"global-blood-plasma-derivatives-market-report-2022-a-40-5-billion-market-in-2021-industry-trends-share-size-growth-opportunity-and-forecasts-to-2027-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-blood-plasma-derivatives-market-report-2022-a-40-5-billion-market-in-2021-industry-trends-share-size-growth-opportunity-and-forecasts-to-2027-researchandmarkets-com\/","title":{"rendered":"Global Blood Plasma Derivatives Market Report 2022: A $40.5 Billion Market in 2021 – Industry Trends, Share, Size, Growth, Opportunity and Forecasts to 2027 – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Blood Plasma Derivatives Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThe global blood plasma derivatives market reached a value of US$ 40.5 billion in 2021. Looking forward, the market is projected to reach a value of US$ 59.8 billion by 2027, exhibiting a CAGR of 6.40% during 2022-2027.\n<\/p>\n

\nKeeping in mind the uncertainties of COVID-19, the analyst is continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different End-use sectors. These insights are included in the report as a major market contributor.\n<\/p>\n

\nBlood plasma derivatives are concentrates of specific proteins prepared from plasma that are obtained through fractionation process. Factor VIII, immunoglobulin, albumin, hyperimmune globulin, factor IX and fresh frozen are some of the common blood plasma derivatives.\n<\/p>\n

\nThey are rich in proteins, minerals, salts, hormones, vitamins and protease inhibitors, due to which they are widely used to kill viruses that cause hepatitis B, hemophilia A, bleeding disorders, immunodeficiency, hepatitis C, hypogammaglobulinemia, hemophilia B and human immunodeficiency virus (HIV).\n<\/p>\n

\nApart from this, blood plasma derivatives assist in enhancing nutrition, controlling body temperature and coagulation of blood, maintaining osmotic pressure, enhancing respiration and excretion, and regulating acid-base balance. Blood plasma derivatives are commonly stored at hospitals, clinics, diagnostic centers and blood transfusion centers.\n<\/p>\n

\nBlood Plasma Derivatives Market Trends<\/strong>\n<\/p>\n

\nThe increasing geriatric population that are more susceptible to developing infectious diseases are creating a positive outlook for the market.\n<\/p>\n

\nBlood plasma contains immunoglobulins that play an important role in the development of immunity and maintain the osmotic pressure in blood vessels, which further prevents the onset immunodeficiency disorders and hemophilia. Moreover, the widespread product adoption to treat coronavirus disease (COVID-19) patients by convalescent plasma treatment is favoring the market growth.\n<\/p>\n

\nAdditionally, various technological innovations in the fractionation process that aids in separating protein concentrates and various components of blood plasma for clinical purposes are providing a considerable boost to the market growth. In line with this, the development of advanced preservation methods, along with the significant improvements in encased procedures for developing targeted therapeutic products are further augmenting the market growth.\n<\/p>\n

\nOther factors, including significant growth in the healthcare industry, increasing awareness regarding blood and plasma donation and the implementation of various government initiatives to promote blood donation camps, are anticipated to drive the market further toward growth.\n<\/p>\n

\nKey Questions Answered in This Report<\/strong>\n<\/p>\n